KT&G's Lil e-cigarettes sell over 3.7 million units worldwide

Sep.08.2022
KT&G's Lil e-cigarettes sell over 3.7 million units worldwide
KT&G's Lil e-cigarette sold 3.79 million units in 2020, with a growing domestic market share and expansion abroad.

KT&G announced on the 7th that their cigarette-style electronic cigarette "Lil" sold a total of 3.79 million units in domestic and overseas markets last year. KT&G launched the cigarette-style electronic cigarette brand "Lil" in South Korea in 2017, and has since introduced new device platforms such as "Lil Mini," "Lil Solid 2.0," and "Lil Hybrid.


According to data from KT&G, Lil's domestic market share grew from 16.1% in 2018 to 31.7% in 2019, almost doubling. In the second quarter of this year, it ranked first among South Korean tobacco companies with a 47% share. In addition, cumulative sales of the Lil series devices exceeded 4 million units as of last year. The company attributes these achievements to its efforts in research and development.


In 2016, KT&G established a specialized intellectual property organization and expanded the compensation system for inventors. Research and development investments have also continued to increase significantly, rising from KRW 4.1 billion in 2017 to KRW 21.4 billion last year.


KT&G is also rapidly expanding into foreign markets. The company has signed a product supply contract with PMI (Philip Morris International) for overseas expansion in Lille in 2020. Starting from three countries - Russia, Ukraine, and Japan - the number of export countries has expanded to 25 including Southeast Asia and Europe in the first quarter of this year.


Especially in Europe, KT&G sells its products in eight countries including Poland, Greece and Italy. The company is expanding its patent applications to accelerate its penetration into the European market. According to the "2021 Korean Enterprise European Patent Index" released by the European Patent Office in March of this year, KT&G has applied for a total of 233 patents in Europe. It ranks third after Samsung and LG.


Foreign securities firms are also paying attention to Liril's overseas market growth. Kelly Jin, a Morgan Stanley researcher, stated in last month's KT&G Q2 earnings report that "the sales growth rate of global cigarette-like electronic cigarettes is enough to attract investor attention.


He continued, "The global impact of the electronic cigarette industry in the tobacco category is currently underestimated, but its growth is sufficient enough to lead the overall growth of cigarette sales. I am looking forward to it," he said.


In Oregon, adults can visit any state-licensed liquor store and purchase a variety of flavored spirits, from cinnamon whiskey to whipped cream vodka. They can also buy caramel dark beers, fruity sour ales, and mango hard seltzers at grocery stores. Cannabis is legally sold in the form of milk chocolate bars and pink lemonade gummies. However, a new proposal being considered by the Multnomah County Commission would soon make it illegal to sell flavored tobacco or nicotine products to adults.


The popularity of flavored alcohol and cannabis has overshadowed accusations directed towards flavored tobacco or e-cigarettes targeting young people. However, proposals to ban these products would be worse than hypocritical. This is also a bad idea for public health and criminal justice.


Experts say that the ban "was driven by a steady increase in youth e-cigarette use." This was a mistake from the outset as the proportion of young people consuming nicotine is actually decreasing. Monitoring the Future surveys show a sharp decline in youth e-cigarette use since reaching its peak around 2019, dropping by 29% from 2020 to 2021 alone. The national Youth Tobacco Survey also tracks a significant decrease in the number of young people using e-cigarettes, though precise year-to-year comparison has become difficult due to method changes caused by the pandemic. Most importantly, youth smoking rates have also dropped to their lowest recorded levels, contradicting concerns that vaping could be a pathway to more dangerous habits.


Teenage use of electronic cigarettes is a real issue, but it should not overshadow the approximately 440,000 Americans who die each year directly from smoking. Renowned tobacco policy experts warn that a singular focus on youth use threatens the potential to prevent preventable deaths from adult smokers, many of whom come from disadvantaged communities.


A complete ban on flavored nicotine products will perpetuate these deaths. Strong evidence suggests that electronic cigarettes are safer than smoking, more effective in helping smokers quit than nicotine gum or patches, and preferred by adult e-cigarette users in non-tobacco flavors. A widespread transition from smoking to e-cigarettes will save millions of lives lost to tobacco. Smart policies will encourage smokers to switch. The proposed ban, however, does the opposite by providing deadly cigarettes in every convenience store while prohibiting the sale of many safer alternatives.


Although the ban does not criminalize the use of nicotine products, it still raises criminal justice concerns. Forcing the sale of menthol cigarettes or flavored e-cigarettes onto the black market could allow existing tax laws to be enforced. In the state of Oregon, the illicit distribution of cigarettes is considered a felony.


Experience in other jurisdictions helps us gain a deeper understanding of how these policies operate in practice. A recent report from Massachusetts shows that the statewide ban on flavored products led to significant shifts in both illegal markets and law enforcement. In one case, police arrested a Latin American clothing store owner for selling mint-flavored products. Another man is facing up to five years in prison for selling illegal tobacco products. We should be mindful that well-intentioned laws can lead to illegal markets, arrests, and imprisonment.


Statement:


This article is compiled from third-party information and is intended solely for the purposes of communication and learning within the industry.


This article does not represent the views of 2FIRSTS and the company is unable to confirm the authenticity and accuracy of its content. The compilation of this article is solely intended for industry-related discussion and research purposes.


Due to limitations in our translation capabilities, the translated article may not fully reflect the views expressed in the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government's positions and statements on all domestic, Hong Kong/Macau/Taiwan-related, and foreign issues.


Information compiled herein belongs to the original media and respective authors. In the event of any copyright infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08